Markedly higher serum IL-36γ levels were found in the MG patients than in the HCs (p < 0.0001, Fig. 1a), but there were no significant differences in the serum IL-36α and IL-36β levels between the two groups (p = 0.325 and p = 0.133, respectively). This evidence concerns the gene IL36A and myasthenia gravis.